Gabelli Funds LLC raised its holdings in shares of InfuSystem Holdings Inc (NYSEAMERICAN:INFU) by 4.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 360,000 shares of the medical instruments supplier’s stock after purchasing an additional 15,000 shares during the period. Gabelli Funds LLC owned about 1.82% of InfuSystem worth $1,904,000 as of its most recent SEC filing.
Separately, AWM Investment Company Inc. increased its stake in InfuSystem by 9.1% during the second quarter. AWM Investment Company Inc. now owns 1,855,362 shares of the medical instruments supplier’s stock valued at $7,978,000 after purchasing an additional 155,092 shares during the last quarter.
In other news, Director Christopher R. Sansone purchased 14,290 shares of the stock in a transaction dated Friday, August 30th. The stock was acquired at an average price of $4.96 per share, for a total transaction of $70,878.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have bought 61,386 shares of company stock valued at $303,671 in the last 90 days.
INFU stock traded down $0.08 during trading on Friday, hitting $7.20. 21,048 shares of the company’s stock traded hands, compared to its average volume of 27,594. InfuSystem Holdings Inc has a 52 week low of $2.94 and a 52 week high of $7.82.
InfuSystem (NYSEAMERICAN:INFU) last released its earnings results on Wednesday, August 14th. The medical instruments supplier reported $0.02 earnings per share for the quarter. The business had revenue of $19.72 million for the quarter.
InfuSystem Company Profile
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Recommended Story: The basics of gap trading strategies
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.